Literature DB >> 30962806

Erratum to "Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study".

Ming Shen1, Meng Wang2, Wenqiang He1, Min He2, Nidan Qiao1, Zengyi Ma1, Zhao Ye1, Qilin Zhang1, Yichao Zhang1, Yeping Yang2, Yanjiao Cai2, Yakupujiang ABuDuoReYiMu3, Yun Lu4, Bin Lu2, Xuefei Shou1, Yongfei Wang1, Hongying Ye2, Yiming Li2, Shiqi Li1, Yao Zhao1, Xiaoyun Cao1, Zhaoyun Zhang2.   

Abstract

[This corrects the article DOI: 10.1155/2018/3015854.].

Entities:  

Year:  2019        PMID： 30962806      PMCID： PMC6431453          DOI： 10.1155/2019/1987417

Source DB:  PubMed          Journal:  Int J Endocrinol        ISSN： 1687-8337            Impact factor:   3.257


In the article titled “Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study” [1], “IGT N = 2” in the Post SSA column in Figure 1 was incorrect due to a production error and should be “IGT N = 12”. The updated Figure 1 is as follows:
Figure 1

Flowchart of prevalence of NGT, IGT, and DM at pretreatment and after SSA treatment, and the change of glucose metabolism status after SSA therapy. NGT: normal glucose tolerance; IGT: impaired glucose tolerance; DM: diabetes mellitus.

  1 in total

1.  Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study.

Authors:  Ming Shen; Meng Wang; Wenqiang He; Min He; Nidan Qiao; Zengyi Ma; Zhao Ye; Qilin Zhang; Yichao Zhang; Yeping Yang; Yanjiao Cai; Yakupujiang ABuDuoReYiMu; Yun Lu; Bin Lu; Xuefei Shou; Yongfei Wang; Hongying Ye; Yiming Li; Shiqi Li; Yao Zhao; Xiaoyun Cao; Zhaoyun Zhang
Journal:  Int J Endocrinol       Date:  2018-04-26       Impact factor: 3.257
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.